BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6207410)

  • 1. Actinomycin D inhibition of monoclonal antibody binding to nucleolar phosphoprotein 37/5.2 (B23).
    Busch RK; Chan PK; Busch H
    Life Sci; 1984 Oct; 35(17):1777-85. PubMed ID: 6207410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in immunolocalization of the phosphoprotein B23 in HeLa cells during serum starvation.
    Chan PK; Aldrich M; Busch H
    Exp Cell Res; 1985 Nov; 161(1):101-10. PubMed ID: 2414117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of actinomycin D analogs on nucleolar phosphoprotein B23 (37,000 daltons/pI 5.1).
    Yung BY; Busch RK; Busch H; Mauger AB; Chan PK
    Biochem Pharmacol; 1985 Nov; 34(22):4059-63. PubMed ID: 2415133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epitope distribution and immunochemical characterization of nucleolar phosphoprotein C23 using ten monoclonal antibodies.
    Freeman JW; Chatterjee A; Ross BE; Busch H
    Mol Cell Biochem; 1985 Sep; 68(1):87-96. PubMed ID: 2414646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and characterization of a hexameric form of nucleolar phosphoprotein B23.
    Yung BY; Chan PK
    Biochim Biophys Acta; 1987 Jul; 925(1):74-82. PubMed ID: 3593769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Translocation of nucleolar phosphoprotein B23 (37 kDa/pI 5.1) induced by selective inhibitors of ribosome synthesis.
    Yung BY; Busch H; Chan PK
    Biochim Biophys Acta; 1985 Dec; 826(4):167-73. PubMed ID: 3907710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short exposure to actinomycin D induces "reversible" translocation of protein B23 as well as "reversible" inhibition of cell growth and RNA synthesis in HeLa cells.
    Yung BY; Bor AM; Chan PK
    Cancer Res; 1990 Sep; 50(18):5987-91. PubMed ID: 1697505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunolocalization of phosphoprotein B23 in proliferating and non-proliferating HeLa cells.
    Yung BY; Bor AM; Yang YH
    Int J Cancer; 1990 Aug; 46(2):272-5. PubMed ID: 2200756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C23 interacts with B23, a putative nucleolar-localization-signal-binding protein.
    Li YP; Busch RK; Valdez BC; Busch H
    Eur J Biochem; 1996 Apr; 237(1):153-8. PubMed ID: 8620867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphoprotein B23 translocation and modulation of actinomycin D and doxorubicin cytotoxicity by dipyridamole in HeLa cells.
    Bor AM; Chang FJ; Yung BY
    Int J Cancer; 1992 Oct; 52(4):658-63. PubMed ID: 1399149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nucleolar protein B23 translocation after doxorubicin treatment in murine tumor cells.
    Chan PK; Aldrich MB; Yung BY
    Cancer Res; 1987 Jul; 47(14):3798-801. PubMed ID: 2439199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclosporin A and verapamil enhancement of daunorubicin-produced nucleolar protein B23 translocation in daunorubicin-resistant and -sensitive human and murine tumor cells.
    Sweet P; Chan PK; Slater LM
    Cancer Res; 1989 Feb; 49(3):677-80. PubMed ID: 2910487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell cycle-dependent translocations of a major nucleolar phosphoprotein, B23, and some characteristics of its variants.
    Zatsepina OV; Todorov IT; Philipova RN; Krachmarov CP; Trendelenburg MF; Jordan EG
    Eur J Cell Biol; 1997 May; 73(1):58-70. PubMed ID: 9174672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization and cellular localization of nucleophosmin/B23 in HeLa cells treated with selected cytotoxic agents (studies of B23-translocation mechanism).
    Chan PK
    Exp Cell Res; 1992 Nov; 203(1):174-81. PubMed ID: 1426041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies of actinomycin D induced B23-translocation in P388D1 cells implanted in DBA/2 mice.
    Finch RA; Chan PK
    Oncology; 1992; 49(3):223-6. PubMed ID: 1495750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification of hnRNP from HeLa cells with a monoclonal antibody and its application in ELISA: detection of autoantibodies.
    Gelpi C; Rodriguez-Sanchez JL; Hardin JA
    Clin Exp Immunol; 1988 Feb; 71(2):281-8. PubMed ID: 2450709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human autoantibodies against a nucleolar protein.
    Kindås-Mügge I
    Biochem Biophys Res Commun; 1989 Sep; 163(2):1119-27. PubMed ID: 2675830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Further evidence that phosphoprotein C23 (110 kD/pI 5.1) is the nucleolar silver staining protein.
    Ochs RL; Busch H
    Exp Cell Res; 1984 May; 152(1):260-5. PubMed ID: 6201373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrophoretic analysis of HeLa cell and human liver nucleolar proteins and antigens.
    Spohn WH; Ahn YS; Busch RK; Busch H
    Cancer Invest; 1985; 3(4):307-20. PubMed ID: 2411364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunodominant RNA recognition motifs of human nucleolin/C23.
    Valdez BC; Henning D; Busch RK; Srivastava M; Busch H
    Mol Immunol; 1995 Nov; 32(16):1207-13. PubMed ID: 8559145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.